Axogen, Inc. — Director's Dealing 2018

Mar 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2018-03-01

Reporting Person: Freitag Gregory Gene (Director, General Counsel & SVP BD)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-01	Common Stock	M	36000	$2.74	Acquired	135666	Direct
2018-03-01	Common Stock	F	2905	$33.95	Disposed	132761	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-01	Employee Stock Option (right to purchase)	$2.74	M	36000	Disposed	2018-12-26	Common Stock (36000)	Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 36,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock swap, the Reporting Person, on a net basis, acquired ownership of an additional 33,095 shares of common stock.